Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Samara Bennett"'
Autor:
Fernando J Rossello, Richard W Tothill, Kara Britt, Kieren D Marini, Jeanette Falzon, David M Thomas, Craig D Peacock, Luigi Marchionni, Jason Li, Samara Bennett, Erwin Tantoso, Tracey Brown, Philip Chan, Luciano G Martelotto, D Neil Watkins
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e74432 (2013)
Next-generation sequencing (NGS) studies in cancer are limited by the amount, quality and purity of tissue samples. In this situation, primary xenografts have proven useful preclinical models. However, the presence of mouse-derived stromal cells repr
Externí odkaz:
https://doaj.org/article/728a70be11b74d5e9bfec58d72aeeeed
Publikováno v:
PharmacoEconomics Open
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ec792a1decca66c2473324f444eb7a1
https://doi.org/10.1007/s41669-020-00225-8
https://doi.org/10.1007/s41669-020-00225-8
Autor:
Jeanette Falzon, Craig D. Peacock, Richard W. Tothill, Kara L. Britt, Fernando J. Rossello, David Thomas, Philip Wai Hong Chan, Erwin Tantoso, Samara Bennett, Kieren D. Marini, Tracey Jean Brown, Luciano G. Martelotto, D. Neil Watkins, Luigi Marchionni, Jason Li
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 9, p e74432 (2013)
PLoS ONE, Vol 8, Iss 9, p e74432 (2013)
Next-generation sequencing (NGS) studies in cancer are limited by the amount, quality and purity of tissue samples. In this situation, primary xenografts have proven useful preclinical models. However, the presence of mouse-derived stromal cells repr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed07f8c66d4f8d8f3939e3799daa91a7
http://europepmc.org/articles/PMC3784448
http://europepmc.org/articles/PMC3784448
Autor:
Craig D. Peacock, Anette Szczepny, D. Neil Watkins, Martin L. Sos, Jamie F. Conklin, Wendy Devereux, Anthony N. Karnezis, Jeanette Falzon, Ribo Guo, Kwon-Sik Park, Ana Markovic, Samara Bennett, Katie Bernard, Beatrice Ospina, Tim Stearns, Martin Peifer, Tracey Jean Brown, Jing Yuan, James K. Chen, Julien Sage, Marion Dorsch, Moe R. Mahjoub, Cory A. Ocasio, Luciano G. Martelotto, Roman K. Thomas, Silvia Buonamici
Publikováno v:
Nature medicine. 17(11)
Small-cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer for which there is no effective treatment1,2. Using a mouse model in which deletion of Rb1 and Trp53 in the lung epithelium of adult mice induces SCLC3,4, we found t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a418574481b0ce95f12cd03b2508cb2
https://pubmed.ncbi.nlm.nih.gov/21983857
https://pubmed.ncbi.nlm.nih.gov/21983857